cd88 Search Results


94
MedChemExpress c5ar1 antagonist
The potential role of C5a in the recruitment of THBS1 + tissue monocytes. (A) The results of a GO analysis of bulk FLR tissue. (B) Bubble plots of THBS1 + tissue monocyte receptor interactions (left) and hepatocyte ligand interactions (right) generated according to the CellphoneDB. The color is coded by the mean intensity of the interaction, and the size of the bubble is determined by the −log 10 P. (C) t-SNE plot showing clusters generated by scRNA-seq data. The color is coded by the expression level of C5a. (D) t-SNE plot showing MP clusters generated by scRNA-seq data, and a violin plot showing the <t>C5aR1</t> expression in all Mo/Mφ populations. (E) GO and KEGG analyses of genes up-regulated in stage II hepatocytes as revealed by scRNA-seq. FLR, future liver remnant; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; Mo, monocytes; MP, Mo/Mφ population; Mφ, macrophages; scRNA-seq, single-cell RNA sequencing; t-SNE, t-distributed stochastic neighbor embedding.
C5ar1 Antagonist, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/CD88+Antibody/pmc13071667-128-6-11
Average 94 stars, based on 1 article reviews
c5ar1 antagonist - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec rrid ab 2659433
The potential role of C5a in the recruitment of THBS1 + tissue monocytes. (A) The results of a GO analysis of bulk FLR tissue. (B) Bubble plots of THBS1 + tissue monocyte receptor interactions (left) and hepatocyte ligand interactions (right) generated according to the CellphoneDB. The color is coded by the mean intensity of the interaction, and the size of the bubble is determined by the −log 10 P. (C) t-SNE plot showing clusters generated by scRNA-seq data. The color is coded by the expression level of C5a. (D) t-SNE plot showing MP clusters generated by scRNA-seq data, and a violin plot showing the <t>C5aR1</t> expression in all Mo/Mφ populations. (E) GO and KEGG analyses of genes up-regulated in stage II hepatocytes as revealed by scRNA-seq. FLR, future liver remnant; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; Mo, monocytes; MP, Mo/Mφ population; Mφ, macrophages; scRNA-seq, single-cell RNA sequencing; t-SNE, t-distributed stochastic neighbor embedding.
Rrid Ab 2659433, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/CD88+(C5AR)+Antibody%2C+anti-human/pmc12651802-63-5-2
Average 93 stars, based on 1 article reviews
rrid ab 2659433 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology c5ar1
In vitro differentiated CD45 + adipocytes were distinct from classical brown adipocytes (A) Oil red O staining of adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . Scale bars, 20μm. (B) mRNA expression of the adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . ( n = 3). (C) mRNA expression of the indicated genes in differentiated adipogenic cells in (A) and white adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ in differentiated cells in (A). (E) RNA-seq of CD45 − and CD45 + adipocytes. Volcano plot of the global gene expression profile ( n = 3). (F) Top 10 genes upregulated and downregulated. (G) (Top) upregulated KEGG pathways and typical genes. (Bottom) downregulated KEGG pathways and typical genes. (H) Expression of <t>C5ar1</t> mRNA in CD45 − and CD45 + ASC and adipogenic differentiated CD45 − and CD45 + adipocytes. (I) Immunoblotting for C5aR1 in adipogenic differentiated CD45 − and CD45 + adipocytes. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM. ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
C5ar1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/C5AR1+Rabbit+pAb/pmc11700647-341-12-2
Average 93 stars, based on 1 article reviews
c5ar1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Bio-Rad mca2456
In vitro differentiated CD45 + adipocytes were distinct from classical brown adipocytes (A) Oil red O staining of adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . Scale bars, 20μm. (B) mRNA expression of the adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . ( n = 3). (C) mRNA expression of the indicated genes in differentiated adipogenic cells in (A) and white adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ in differentiated cells in (A). (E) RNA-seq of CD45 − and CD45 + adipocytes. Volcano plot of the global gene expression profile ( n = 3). (F) Top 10 genes upregulated and downregulated. (G) (Top) upregulated KEGG pathways and typical genes. (Bottom) downregulated KEGG pathways and typical genes. (H) Expression of <t>C5ar1</t> mRNA in CD45 − and CD45 + ASC and adipogenic differentiated CD45 − and CD45 + adipocytes. (I) Immunoblotting for C5aR1 in adipogenic differentiated CD45 − and CD45 + adipocytes. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM. ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
Mca2456, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/Rat+anti+Mouse+CD88/10__1096_slash_fj__202001163r-69-82-86
Average 93 stars, based on 1 article reviews
mca2456 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Proteintech c5a
In vitro differentiated CD45 + adipocytes were distinct from classical brown adipocytes (A) Oil red O staining of adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . Scale bars, 20μm. (B) mRNA expression of the adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . ( n = 3). (C) mRNA expression of the indicated genes in differentiated adipogenic cells in (A) and white adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ in differentiated cells in (A). (E) RNA-seq of CD45 − and CD45 + adipocytes. Volcano plot of the global gene expression profile ( n = 3). (F) Top 10 genes upregulated and downregulated. (G) (Top) upregulated KEGG pathways and typical genes. (Bottom) downregulated KEGG pathways and typical genes. (H) Expression of <t>C5ar1</t> mRNA in CD45 − and CD45 + ASC and adipogenic differentiated CD45 − and CD45 + adipocytes. (I) Immunoblotting for C5aR1 in adipogenic differentiated CD45 − and CD45 + adipocytes. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM. ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
C5a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/C5aR+Antibody/bio_rxiv__2024__09__24__614691-53-5-9
Average 93 stars, based on 1 article reviews
c5a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Bio-Rad mouse anti human c5ar1 fitc antibody
Expression profile of shed MVs in multiple trauma. (A) Representative dot plot of a healthy control (left) and a multiple trauma patient (right). Annexin V- positive MV fraction was analyzed for CD66b and <t>C5aR1</t> expression. FITC was used for C5aR1 staining, and APC-Cy7 for CD66b. Q2 represents AnnexinV + , C5aR1 + , CD66b + MVs positive MV fraction. (B) Quantitative analysis for granulocyte-derived MVs and (C,D) granulocyte-derived MVs expressing C5aR1 in 5 μl of MV enriched plasma, respectively. n = 8–10, * p < 0.05 compared to healthy.
Mouse Anti Human C5ar1 Fitc Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/Mouse+anti+Human+CD88/pmc07492592-71-4-9
Average 93 stars, based on 1 article reviews
mouse anti human c5ar1 fitc antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Miltenyi Biotec cd88
Expression profile of shed MVs in multiple trauma. (A) Representative dot plot of a healthy control (left) and a multiple trauma patient (right). Annexin V- positive MV fraction was analyzed for CD66b and <t>C5aR1</t> expression. FITC was used for C5aR1 staining, and APC-Cy7 for CD66b. Q2 represents AnnexinV + , C5aR1 + , CD66b + MVs positive MV fraction. (B) Quantitative analysis for granulocyte-derived MVs and (C,D) granulocyte-derived MVs expressing C5aR1 in 5 μl of MV enriched plasma, respectively. n = 8–10, * p < 0.05 compared to healthy.
Cd88, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/CD88+(C5AR)+Antibody%2C+anti-mouse%2C+REAfinity/bio_rxiv__2022__11__27__518117-220-28-32
Average 92 stars, based on 1 article reviews
cd88 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
OriGene full length murine c5ar
Figure 1. Immunohistochemistry of <t>C5aR</t> in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.
Full Length Murine C5ar, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/C5ar1+(NM_007577)+Mouse+Tagged+ORF+Clone+Lentiviral+Particle/pm25682807-47-14-20
Average 90 stars, based on 1 article reviews
full length murine c5ar - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Bio-Rad anti rat cd88 fitc
Figure 1. Immunohistochemistry of <t>C5aR</t> in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.
Anti Rat Cd88 Fitc, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/Mouse+anti+Rat+CD88/pm23479227-107-30-35
Average 93 stars, based on 1 article reviews
anti rat cd88 fitc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
OriGene cd88 c5ar1
Figure 1. Immunohistochemistry of <t>C5aR</t> in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.
Cd88 C5ar1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/CD88+%2F+C5R1+Chicken+Polyclonal+Antibody/10__1097_slash_shk__0000000000001536-96-10-11
Average 90 stars, based on 1 article reviews
cd88 c5ar1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene c5 overexpression vector
Figure 1. Immunohistochemistry of <t>C5aR</t> in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.
C5 Overexpression Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/C5ar1+(NM_007577)+Mouse+Tagged+ORF+Clone/pm33799167-63-17-23
Average 90 stars, based on 1 article reviews
c5 overexpression vector - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene anti c5ar cd88
Figure 1. Immunohistochemistry of <t>C5aR</t> in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.
Anti C5ar Cd88, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd88/CD88+%2F+C5R1+Rat+Monoclonal+Antibody/pmc03592996-254-5-7
Average 90 stars, based on 1 article reviews
anti c5ar cd88 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


The potential role of C5a in the recruitment of THBS1 + tissue monocytes. (A) The results of a GO analysis of bulk FLR tissue. (B) Bubble plots of THBS1 + tissue monocyte receptor interactions (left) and hepatocyte ligand interactions (right) generated according to the CellphoneDB. The color is coded by the mean intensity of the interaction, and the size of the bubble is determined by the −log 10 P. (C) t-SNE plot showing clusters generated by scRNA-seq data. The color is coded by the expression level of C5a. (D) t-SNE plot showing MP clusters generated by scRNA-seq data, and a violin plot showing the C5aR1 expression in all Mo/Mφ populations. (E) GO and KEGG analyses of genes up-regulated in stage II hepatocytes as revealed by scRNA-seq. FLR, future liver remnant; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; Mo, monocytes; MP, Mo/Mφ population; Mφ, macrophages; scRNA-seq, single-cell RNA sequencing; t-SNE, t-distributed stochastic neighbor embedding.

Journal: Hepatobiliary Surgery and Nutrition

Article Title: EREG-secreting THBS1 + tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure

doi: 10.21037/hbsn-24-391

Figure Lengend Snippet: The potential role of C5a in the recruitment of THBS1 + tissue monocytes. (A) The results of a GO analysis of bulk FLR tissue. (B) Bubble plots of THBS1 + tissue monocyte receptor interactions (left) and hepatocyte ligand interactions (right) generated according to the CellphoneDB. The color is coded by the mean intensity of the interaction, and the size of the bubble is determined by the −log 10 P. (C) t-SNE plot showing clusters generated by scRNA-seq data. The color is coded by the expression level of C5a. (D) t-SNE plot showing MP clusters generated by scRNA-seq data, and a violin plot showing the C5aR1 expression in all Mo/Mφ populations. (E) GO and KEGG analyses of genes up-regulated in stage II hepatocytes as revealed by scRNA-seq. FLR, future liver remnant; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; Mo, monocytes; MP, Mo/Mφ population; Mφ, macrophages; scRNA-seq, single-cell RNA sequencing; t-SNE, t-distributed stochastic neighbor embedding.

Article Snippet: For C5a blockade, PMX-53, a specific C5aR1 antagonist, was used (HY-106178, MedChemExpress, Shanghai, China).

Techniques: Generated, Expressing, Single Cell, RNA Sequencing

THBS1 + tissue monocytes were recruited through C5a. (A) Multiplexed immunofluorescence staining, showing the distribution of C5aR1 + monocytes (CD14 + C5aR1 + ). (B) Immunohistochemical staining of C5a at ALPPS stage I (upper left) and stage II (lower left). The H-score shows the up-regulation of C5a expression in hepatocytes from ALPPS stage I to stage II. *, P<0.05. (C) Liver samples from the murine ALPSS model on POD1 and POD5 (left). The boxplot represents comparisons of the FLR to body weight ratio between the control group and PMX-53 group on POD1 and POD5. (D) Immunohistochemical staining of Ki-67 for the control group and PMX-5 group on POD1 and POD5 (left). The boxplot shows comparisons of the ratios of Ki-67 + cells between the control and PMX-53 group on POD1 and POD5 (right). (E) Boxplot showing the EREG expression in the control and PMX-53 group on POD1 and POD5. (F) Schematic diagram of the ALPPS-induced liver regeneration. *, P<0.05 (actual P values were reported in results). ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; EREG, epiregulin; IF, immunofluorescence; IHC, immunohistochemistry; FLR, future liver remnant; POD, post-operation day.

Journal: Hepatobiliary Surgery and Nutrition

Article Title: EREG-secreting THBS1 + tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure

doi: 10.21037/hbsn-24-391

Figure Lengend Snippet: THBS1 + tissue monocytes were recruited through C5a. (A) Multiplexed immunofluorescence staining, showing the distribution of C5aR1 + monocytes (CD14 + C5aR1 + ). (B) Immunohistochemical staining of C5a at ALPPS stage I (upper left) and stage II (lower left). The H-score shows the up-regulation of C5a expression in hepatocytes from ALPPS stage I to stage II. *, P<0.05. (C) Liver samples from the murine ALPSS model on POD1 and POD5 (left). The boxplot represents comparisons of the FLR to body weight ratio between the control group and PMX-53 group on POD1 and POD5. (D) Immunohistochemical staining of Ki-67 for the control group and PMX-5 group on POD1 and POD5 (left). The boxplot shows comparisons of the ratios of Ki-67 + cells between the control and PMX-53 group on POD1 and POD5 (right). (E) Boxplot showing the EREG expression in the control and PMX-53 group on POD1 and POD5. (F) Schematic diagram of the ALPPS-induced liver regeneration. *, P<0.05 (actual P values were reported in results). ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; EREG, epiregulin; IF, immunofluorescence; IHC, immunohistochemistry; FLR, future liver remnant; POD, post-operation day.

Article Snippet: For C5a blockade, PMX-53, a specific C5aR1 antagonist, was used (HY-106178, MedChemExpress, Shanghai, China).

Techniques: Immunofluorescence, Staining, Immunohistochemical staining, Expressing, Control, Ligation, Immunohistochemistry

In vitro differentiated CD45 + adipocytes were distinct from classical brown adipocytes (A) Oil red O staining of adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . Scale bars, 20μm. (B) mRNA expression of the adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . ( n = 3). (C) mRNA expression of the indicated genes in differentiated adipogenic cells in (A) and white adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ in differentiated cells in (A). (E) RNA-seq of CD45 − and CD45 + adipocytes. Volcano plot of the global gene expression profile ( n = 3). (F) Top 10 genes upregulated and downregulated. (G) (Top) upregulated KEGG pathways and typical genes. (Bottom) downregulated KEGG pathways and typical genes. (H) Expression of C5ar1 mRNA in CD45 − and CD45 + ASC and adipogenic differentiated CD45 − and CD45 + adipocytes. (I) Immunoblotting for C5aR1 in adipogenic differentiated CD45 − and CD45 + adipocytes. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM. ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet: In vitro differentiated CD45 + adipocytes were distinct from classical brown adipocytes (A) Oil red O staining of adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . Scale bars, 20μm. (B) mRNA expression of the adipogenic differentiation of isolated CD45 − and CD45 + ASCs in vitro . ( n = 3). (C) mRNA expression of the indicated genes in differentiated adipogenic cells in (A) and white adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ in differentiated cells in (A). (E) RNA-seq of CD45 − and CD45 + adipocytes. Volcano plot of the global gene expression profile ( n = 3). (F) Top 10 genes upregulated and downregulated. (G) (Top) upregulated KEGG pathways and typical genes. (Bottom) downregulated KEGG pathways and typical genes. (H) Expression of C5ar1 mRNA in CD45 − and CD45 + ASC and adipogenic differentiated CD45 − and CD45 + adipocytes. (I) Immunoblotting for C5aR1 in adipogenic differentiated CD45 − and CD45 + adipocytes. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM. ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Article Snippet: Anti-rabbit IgG (ABclonal, AS014) was used as the second antibody for UCP1, C5aR1, PPARγ, β-ACTIN and HSP90.

Techniques: In Vitro, Staining, Isolation, Expressing, Western Blot, RNA Sequencing, Gene Expression, Two Tailed Test

The loss of the C5ar1 gene in adipocytes during the perinatal period decreased the thermogenesis ability of newborn mice (A) Administration of shRNA- C5ar1 in CD45 + adipocytes significantly suppressed C5ar1 expression compared to the control group. (Left) RT-qPCR for C5ar1 in shNC and sh C5ar1 CD45 + adipocytes. (Right) Immunoblotting for C5aR1 in shNC and sh C5ar1 CD45 + adipocytes ( n = 3). (B) Oil red O staining of shNC and sh C5ar1 CD45 + adipocytes. Scale bars, 20μm. (C) The mRNA expression of the indicated genes of C5ar1 knockdown differentiated CD45 + adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ of C5ar1 knockdown differentiated CD45 + adipocytes ( n = 3). (E) C5ar1 AKO mice ( C5ar1 flox/flox ; Adipoq Cre + ) were generated by breeding C5ar1 flox/flox mice with Adiponectin -Cre mice. (F) Immunofluorescence staining of UCP1 and C5aR1 in the BAT of the control and C5ar1 AKO neonatal mice. Scale bars, 50μm. (G) (left)Infrared thermo-imaging 5 min after the beginning of cold challenge. (Right) back skin temperature during cold challenge (22° C) (control, n = 8 AKO, n = 7). (H) Body weight and BAT/body weight ratio in control and C5ar1 AKO neonatal mice. (I) Gross appearance of the interscapular BAT of the control and C5ar1 AKO neonatal mice. Scale bars, 1mm. (J) H&E (Top) and UCP1 immunohistochemical staining (bottom). Scale bars, 20μm. BAT adipocyte sizes of control and C5ar1 AKO neonatal mice (right). (K) Relative mRNA expression of indicated genes of BAT from control and C5ar1 AKO neonatal mice ( n = 8). (L) Immunoblotting for UCP1 of BAT from control and C5ar1 AKO neonatal mice ( n = 6). (M) RNA-seq of BAT from control and C5ar1 AKO neonatal mice. Volcano plot of the global gene expression profile ( n = 3). (N) Upregulated KEGG pathways and downregulated KEGG pathways. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet: The loss of the C5ar1 gene in adipocytes during the perinatal period decreased the thermogenesis ability of newborn mice (A) Administration of shRNA- C5ar1 in CD45 + adipocytes significantly suppressed C5ar1 expression compared to the control group. (Left) RT-qPCR for C5ar1 in shNC and sh C5ar1 CD45 + adipocytes. (Right) Immunoblotting for C5aR1 in shNC and sh C5ar1 CD45 + adipocytes ( n = 3). (B) Oil red O staining of shNC and sh C5ar1 CD45 + adipocytes. Scale bars, 20μm. (C) The mRNA expression of the indicated genes of C5ar1 knockdown differentiated CD45 + adipocytes ( n = 3). (D) Immunoblotting for UCP1 and PPARγ of C5ar1 knockdown differentiated CD45 + adipocytes ( n = 3). (E) C5ar1 AKO mice ( C5ar1 flox/flox ; Adipoq Cre + ) were generated by breeding C5ar1 flox/flox mice with Adiponectin -Cre mice. (F) Immunofluorescence staining of UCP1 and C5aR1 in the BAT of the control and C5ar1 AKO neonatal mice. Scale bars, 50μm. (G) (left)Infrared thermo-imaging 5 min after the beginning of cold challenge. (Right) back skin temperature during cold challenge (22° C) (control, n = 8 AKO, n = 7). (H) Body weight and BAT/body weight ratio in control and C5ar1 AKO neonatal mice. (I) Gross appearance of the interscapular BAT of the control and C5ar1 AKO neonatal mice. Scale bars, 1mm. (J) H&E (Top) and UCP1 immunohistochemical staining (bottom). Scale bars, 20μm. BAT adipocyte sizes of control and C5ar1 AKO neonatal mice (right). (K) Relative mRNA expression of indicated genes of BAT from control and C5ar1 AKO neonatal mice ( n = 8). (L) Immunoblotting for UCP1 of BAT from control and C5ar1 AKO neonatal mice ( n = 6). (M) RNA-seq of BAT from control and C5ar1 AKO neonatal mice. Volcano plot of the global gene expression profile ( n = 3). (N) Upregulated KEGG pathways and downregulated KEGG pathways. Statistical significance was assessed by two-tailed Student’s t test. Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Article Snippet: Anti-rabbit IgG (ABclonal, AS014) was used as the second antibody for UCP1, C5aR1, PPARγ, β-ACTIN and HSP90.

Techniques: shRNA, Expressing, Control, Quantitative RT-PCR, Western Blot, Staining, Knockdown, Generated, Immunofluorescence, Imaging, Immunohistochemical staining, RNA Sequencing, Gene Expression, Two Tailed Test

C5ar1 knockdown in CD45 + brown adipocytes promote PF4 release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet: C5ar1 knockdown in CD45 + brown adipocytes promote PF4 release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Article Snippet: Anti-rabbit IgG (ABclonal, AS014) was used as the second antibody for UCP1, C5aR1, PPARγ, β-ACTIN and HSP90.

Techniques: Knockdown, Expressing, Control, Concentration Assay, Cell Culture, Western Blot, Two Tailed Test

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet:

Article Snippet: Anti-rabbit IgG (ABclonal, AS014) was used as the second antibody for UCP1, C5aR1, PPARγ, β-ACTIN and HSP90.

Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, cDNA Synthesis, SYBR Green Assay, Sequencing, Software

Expression profile of shed MVs in multiple trauma. (A) Representative dot plot of a healthy control (left) and a multiple trauma patient (right). Annexin V- positive MV fraction was analyzed for CD66b and C5aR1 expression. FITC was used for C5aR1 staining, and APC-Cy7 for CD66b. Q2 represents AnnexinV + , C5aR1 + , CD66b + MVs positive MV fraction. (B) Quantitative analysis for granulocyte-derived MVs and (C,D) granulocyte-derived MVs expressing C5aR1 in 5 μl of MV enriched plasma, respectively. n = 8–10, * p < 0.05 compared to healthy.

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: Expression profile of shed MVs in multiple trauma. (A) Representative dot plot of a healthy control (left) and a multiple trauma patient (right). Annexin V- positive MV fraction was analyzed for CD66b and C5aR1 expression. FITC was used for C5aR1 staining, and APC-Cy7 for CD66b. Q2 represents AnnexinV + , C5aR1 + , CD66b + MVs positive MV fraction. (B) Quantitative analysis for granulocyte-derived MVs and (C,D) granulocyte-derived MVs expressing C5aR1 in 5 μl of MV enriched plasma, respectively. n = 8–10, * p < 0.05 compared to healthy.

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Expressing, Control, Staining, Derivative Assay, Clinical Proteomics

C5a alters MV shedding in PMNs. (A) PMNs were stimulated for 0, 10, 30, 60, and 240 min with C5a (100 ng/ml) or LPS (5 μg/ml) and supernatants were analyzed by FACS. Untreated cells served as control. n = 10, One-Way ANOVA followed by Student-Neuman-Keuls post-hoc testing was performed for each time point, * p < 0.05. (B) MVs from supernatants were further analyzed for expression of C5aR1 by FACS. n = 3 per group, * p < 0.05. (C) Heat map and gene list of selected and differentially regulated genes upon C5a treatment in in neutrophils after 1 h ( n = 3 per group).

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: C5a alters MV shedding in PMNs. (A) PMNs were stimulated for 0, 10, 30, 60, and 240 min with C5a (100 ng/ml) or LPS (5 μg/ml) and supernatants were analyzed by FACS. Untreated cells served as control. n = 10, One-Way ANOVA followed by Student-Neuman-Keuls post-hoc testing was performed for each time point, * p < 0.05. (B) MVs from supernatants were further analyzed for expression of C5aR1 by FACS. n = 3 per group, * p < 0.05. (C) Heat map and gene list of selected and differentially regulated genes upon C5a treatment in in neutrophils after 1 h ( n = 3 per group).

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Control, Expressing

Effect of the C5aR1-antagonist PMX53 on vesicle shedding. (A) Upper panel shows merged image of F-actin staining (red, Phalloidin-Alexa Flour 568) and nuclei staining (DAPI) of fixed PMNs, untreated, after treatment with native human C5a (100 ng/ml), and C5a treatment in combination with PMX53 (10 μM) for 1 h, respectively at 630x magnification. Lower panel with further zoom-in on PMNs from the upper panel, white arrows indicate shed MVs. Experiment was repeated at least three times. (B) Quantitative analysis of shed MV at different C5a concentrations and in presence of the PMX53 together and alone in 10 μl supernatant ( n = 3). * p < 0.05.

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: Effect of the C5aR1-antagonist PMX53 on vesicle shedding. (A) Upper panel shows merged image of F-actin staining (red, Phalloidin-Alexa Flour 568) and nuclei staining (DAPI) of fixed PMNs, untreated, after treatment with native human C5a (100 ng/ml), and C5a treatment in combination with PMX53 (10 μM) for 1 h, respectively at 630x magnification. Lower panel with further zoom-in on PMNs from the upper panel, white arrows indicate shed MVs. Experiment was repeated at least three times. (B) Quantitative analysis of shed MV at different C5a concentrations and in presence of the PMX53 together and alone in 10 μl supernatant ( n = 3). * p < 0.05.

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Staining

PMX53 and NAV2729 show similar effects in blocking C5aR1-positive MV shedding. Representative flow cytometry panels for C5aR1 expression (FITC) (A) on PMNs or (B) in PMN supernatants including C5aR1 + MV counts in Q2 after 1 h stimulation in the presence of PMX53. Quantitative analysis of flow cytometry data showing (C) C5aR1 expression on PMN surfaces (FITC MFI) and (D) C5aR1 + MV counts. Quantitative flow cytometry analysis including the MV-specific inhibitor NAV2729 (10 μM) (E) for C5aR1 expression (FITC MFI) on PMNs and (F) C5aR1 + MV counts in 10 μl PMN supernatants after 1 h, n = 4 per group, respectively. * p < 0.05.

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: PMX53 and NAV2729 show similar effects in blocking C5aR1-positive MV shedding. Representative flow cytometry panels for C5aR1 expression (FITC) (A) on PMNs or (B) in PMN supernatants including C5aR1 + MV counts in Q2 after 1 h stimulation in the presence of PMX53. Quantitative analysis of flow cytometry data showing (C) C5aR1 expression on PMN surfaces (FITC MFI) and (D) C5aR1 + MV counts. Quantitative flow cytometry analysis including the MV-specific inhibitor NAV2729 (10 μM) (E) for C5aR1 expression (FITC MFI) on PMNs and (F) C5aR1 + MV counts in 10 μl PMN supernatants after 1 h, n = 4 per group, respectively. * p < 0.05.

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Blocking Assay, Flow Cytometry, Expressing

C5aR1 expression and MV shedding after incubation of PMNs with serum obtained from PT patients (S PT) and healthy donors (S Healthy). PMNs were incubated in HBSS++ buffer supplemented with 20% of pooled human serum from PT patients or from healthy donors for 1 h. (A) Quantification of C5aR1 expression on PMNs and (B) C5aR1 + MV counts in 10 μl of PMN supernatants after incubation. n = 4, * p < 0.05.

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: C5aR1 expression and MV shedding after incubation of PMNs with serum obtained from PT patients (S PT) and healthy donors (S Healthy). PMNs were incubated in HBSS++ buffer supplemented with 20% of pooled human serum from PT patients or from healthy donors for 1 h. (A) Quantification of C5aR1 expression on PMNs and (B) C5aR1 + MV counts in 10 μl of PMN supernatants after incubation. n = 4, * p < 0.05.

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Expressing, Incubation

Model for C5a-mediated alterations on MV shedding for neutrophils after PT. PT causes an early activation of complement generating increased C5a concentrations. C5a induces activity of the small GTPase Arf6, which is dependent on C5aR1 signaling. Additionally, specific changes in gene expression pattern are involved in MV shedding. Resting PMNs show physiological MV shedding and composition, which have no inflammatory potential. In contrast, PMNs incubated with C5a loose C5aR1 surface expression induced by C5aR1 signaling and Arf6-mediated shedding of C5aR1-positive MVs. Furthermore, these MVs show increased CD66b and C5aR1 expression, which show pro-inflammatory features when incubated with resting PMNs. C5a induces shedding of MVs, which lead to NAPDH oxidase activation, ROS generation and MPO release in resting PMNs. Moreover, IL-6 generation was observed when these MVs were incubated in whole blood. PMX53 and the Arf6-selective compound NAV2729 can block the shedding of C5aR1-positive MVs from PMN surfaces and its inflammatory effects.

Journal: Frontiers in Immunology

Article Title: Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients

doi: 10.3389/fimmu.2020.01789

Figure Lengend Snippet: Model for C5a-mediated alterations on MV shedding for neutrophils after PT. PT causes an early activation of complement generating increased C5a concentrations. C5a induces activity of the small GTPase Arf6, which is dependent on C5aR1 signaling. Additionally, specific changes in gene expression pattern are involved in MV shedding. Resting PMNs show physiological MV shedding and composition, which have no inflammatory potential. In contrast, PMNs incubated with C5a loose C5aR1 surface expression induced by C5aR1 signaling and Arf6-mediated shedding of C5aR1-positive MVs. Furthermore, these MVs show increased CD66b and C5aR1 expression, which show pro-inflammatory features when incubated with resting PMNs. C5a induces shedding of MVs, which lead to NAPDH oxidase activation, ROS generation and MPO release in resting PMNs. Moreover, IL-6 generation was observed when these MVs were incubated in whole blood. PMX53 and the Arf6-selective compound NAV2729 can block the shedding of C5aR1-positive MVs from PMN surfaces and its inflammatory effects.

Article Snippet: MVs were stained with mouse anti-human C5aR1-FITC antibody (MCA2059F, Bio-Rad) and mouse anti-human CD66b-APC-Cy7 (305126, Biolegend) or the respective isotype controls in AV binding buffer.

Techniques: Activation Assay, Activity Assay, Gene Expression, Incubation, Expressing, Blocking Assay

Figure 1. Immunohistochemistry of C5aR in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.

Journal: Oncology reports

Article Title: C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.

doi: 10.3892/or.2015.3800

Figure Lengend Snippet: Figure 1. Immunohistochemistry of C5aR in the RCC specimens. FFPE samples of RCC were stained with the anti-C5aR antibody. Representative examples of C5aR-negative RCC without metastasis (A) and C5aR-expressing mRCC (B) are shown. Original, x200 magnification. C5aR, C5a receptor; RCC, renal cell carcinoma; mRCC, metastatic RCC; FFPE, formalin-fixed paraffin-embedded.

Article Snippet: Establishment of C5aR stably expressing Renca cells and in vivo study. pCMV-C5aR that encodes full-length murine C5aR was purchased from OriGene Technologies (Rockville, MD, USA).

Techniques: Immunohistochemistry, Staining, Expressing, Formalin-fixed Paraffin-Embedded

Figure 3. C5a elicits cytoskeletal rearrangement and changes in cellular mor- phology in the C5aR-expressing Renca cells. Renca/empty cells (A-D) and Renca/C5aR cells (E-G) were incubated with C5a (10 nM) and fixed at the indicated time-points. F-actin was visualized by immunofluorescent staining with Alexa 488-conjugated phalloidin (green), and nuclei with TO-PRO-3 (red). Scale bars, 20 µm. Arrowheads and the arrow indicate membrane ruffing and lamellipodia, respectively. C5aR, C5a receptor.

Journal: Oncology reports

Article Title: C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.

doi: 10.3892/or.2015.3800

Figure Lengend Snippet: Figure 3. C5a elicits cytoskeletal rearrangement and changes in cellular mor- phology in the C5aR-expressing Renca cells. Renca/empty cells (A-D) and Renca/C5aR cells (E-G) were incubated with C5a (10 nM) and fixed at the indicated time-points. F-actin was visualized by immunofluorescent staining with Alexa 488-conjugated phalloidin (green), and nuclei with TO-PRO-3 (red). Scale bars, 20 µm. Arrowheads and the arrow indicate membrane ruffing and lamellipodia, respectively. C5aR, C5a receptor.

Article Snippet: Establishment of C5aR stably expressing Renca cells and in vivo study. pCMV-C5aR that encodes full-length murine C5aR was purchased from OriGene Technologies (Rockville, MD, USA).

Techniques: Expressing, Incubation, Staining, Membrane

Figure 4. C5a-C5aR axis triggers ERK and PI3K-dependent cellular inva- sion. (A) Renca-derived cells were stimulated with or without 10 nM C5a for 15 min after serum starvation for 24 h. Samples were harvested and subjected to immunoblotting using antibodies indicated. (B and C) Invasion assays were carried out using (B) Renca/empty and Renca/C5aR cells or (C) Renca/C5aR cells only. (C) Medium in both the upper and lower wells were mixed with the indicated kinase inhibitors or vehicle (DMSO). U0126 was used at 20 µM and PI-103 was used at 0.5 µM. Data are presented as the mean ± SD. *P<0.02 and **P<0.01. C5aR, C5a receptor.

Journal: Oncology reports

Article Title: C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.

doi: 10.3892/or.2015.3800

Figure Lengend Snippet: Figure 4. C5a-C5aR axis triggers ERK and PI3K-dependent cellular inva- sion. (A) Renca-derived cells were stimulated with or without 10 nM C5a for 15 min after serum starvation for 24 h. Samples were harvested and subjected to immunoblotting using antibodies indicated. (B and C) Invasion assays were carried out using (B) Renca/empty and Renca/C5aR cells or (C) Renca/C5aR cells only. (C) Medium in both the upper and lower wells were mixed with the indicated kinase inhibitors or vehicle (DMSO). U0126 was used at 20 µM and PI-103 was used at 0.5 µM. Data are presented as the mean ± SD. *P<0.02 and **P<0.01. C5aR, C5a receptor.

Article Snippet: Establishment of C5aR stably expressing Renca cells and in vivo study. pCMV-C5aR that encodes full-length murine C5aR was purchased from OriGene Technologies (Rockville, MD, USA).

Techniques: Derivative Assay, Western Blot